What is the workup for a 6-year-old male patient with rheumatic heart disease, pulmonary congestion, and impaired renal function, currently on Furosemide (Lasix) and Captopril (Angiotensin-Converting Enzyme inhibitor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Rheumatic Heart Disease in a 6-Year-Old with Pulmonary Congestion

In a 6-year-old with suspected rheumatic heart disease and pulmonary congestion, immediately obtain an echocardiography with Doppler to confirm cardiac dysfunction and assess valvular involvement, along with ECG, chest X-ray, complete blood count, electrolytes, renal function tests, and inflammatory markers (ESR/CRP) to establish the diagnosis and guide management. 1, 2

Essential Diagnostic Tests

Cardiac Imaging - First Priority

  • Echocardiography with Doppler is the cornerstone diagnostic test that must be performed to objectively confirm cardiac dysfunction, assess left ventricular ejection fraction, evaluate valvular function (particularly mitral and aortic regurgitation/stenosis typical of rheumatic heart disease), and assess diastolic filling patterns 1, 2

  • Echocardiography will distinguish between systolic dysfunction (LVEF <45-50%) and preserved systolic function, which is critical for management decisions 1, 2

  • The study should specifically evaluate for valvular thickening, restricted leaflet motion, and regurgitation patterns characteristic of rheumatic heart disease 1

Electrocardiogram

  • A 12-lead ECG must be obtained in all cases, as a completely normal ECG has a negative predictive value exceeding 90% for excluding left ventricular systolic dysfunction 1, 2, 3

  • Look specifically for evidence of atrial enlargement, ventricular hypertrophy, conduction abnormalities, or arrhythmias that may accompany rheumatic heart disease 1

  • QRS width >120 ms suggests cardiac dyssynchrony that may require specific treatment considerations 1

Chest X-Ray

  • Obtain chest X-ray in two planes to assess for cardiomegaly, pulmonary congestion, and pleural effusions 1, 2, 3

  • This is particularly important given the current pulmonary congestion to evaluate severity and response to diuretic therapy 1

  • Note that cardiomegaly can be absent on chest X-ray even in chronic heart failure, so a normal X-ray does not exclude significant cardiac dysfunction 3

Laboratory Evaluation

Routine Blood Work - Essential

  • Complete blood count (hemoglobin, leukocytes, platelets) to assess for anemia and infection 1, 2

  • Serum electrolytes (sodium, potassium, chloride) - critical given current furosemide therapy 1, 2

  • Serum creatinine and blood urea nitrogen to assess renal function, especially important as the patient is on both furosemide and captopril which can affect renal function 1, 2

  • Urinalysis as part of routine evaluation 1, 2

  • Liver function tests to assess hepatic congestion and baseline function 1, 2

  • Fasting blood glucose for metabolic assessment 1, 2

Rheumatic Fever-Specific Tests

  • Anti-streptolysin O (ASO) titer and anti-DNase B to document recent streptococcal infection (though these may be normal if the acute rheumatic fever episode occurred months prior) 2

  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to assess for ongoing inflammation 2

  • Throat culture if acute presentation to identify active streptococcal infection 2

Monitoring Current Medications

Critical Monitoring Given Furosemide and Captopril Use

  • Monitor electrolytes (especially potassium) 1-2 weeks after medication initiation and 1-2 weeks after any dose adjustment, then every 4 months thereafter 1

  • Monitor renal function closely - an increase in creatinine up to 50% above baseline or to 3 mg/dL (266 μmol/L), whichever is greater, is acceptable with ACE inhibitor therapy 1

  • At furosemide doses ≤2 mg/kg/day, excess potassium loss generally does not occur and potassium supplementation may not be needed 4

  • Monitor for hyperkalemia (K+ >5.0 mmol/L) which requires dose adjustment or specialist consultation 1

  • Monitor fluid status and urine output, targeting >1 mL/kg/hour with furosemide therapy 4

  • Monitor blood pressure for symptomatic hypotension, particularly with the combination of furosemide and captopril 1, 4

  • Monitor weight to assess fluid status and response to diuretic therapy 4

Additional Tests in Selected Cases

If Initial Workup is Inconclusive

  • Cardiac magnetic resonance (CMR) should be considered when echocardiography is inconclusive or technically limited, particularly for detecting myocardial fibrosis 3

  • Exercise testing has limited diagnostic value but may be useful for prognostic stratification once the patient is stabilized 1, 2

  • Natriuretic peptides (BNP or NT-proBNP) can help exclude heart failure if clinical diagnosis is uncertain, with BNP <35 pg/mL or NT-proBNP <125 pg/mL making chronic heart failure unlikely 1, 2, 3

Common Pitfalls to Avoid

  • Do not rely solely on chest X-ray, as cardiomegaly may be absent on imaging despite significant cardiac dysfunction 3

  • Do not dismiss the diagnosis with symptoms alone - objective evidence of cardiac dysfunction through echocardiography is mandatory for diagnosis 1, 2

  • Do not stop ACE inhibitor therapy for mild increases in creatinine or potassium - it is very rarely necessary to stop an ACE inhibitor, and clinical deterioration is likely if treatment is withdrawn; seek specialist advice before discontinuation 1

  • Monitor for worsening renal function carefully - if creatinine increases by 100% or to above 4 mg/dL (354 μmol/L), or if potassium rises to 6.0 mmol/L, seek specialist advice immediately 1

  • Never exceed furosemide 6 mg/kg/day for longer than 1 week due to significant ototoxicity risk, with an absolute maximum of 10 mg/kg/day for severe edema 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Cardiomegaly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Congestive Heart Failure in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.